Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+73.5%
5Y CAGR+63.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+73.5%/yr
vs +13.5%/yr prior
5Y CAGR
+63.0%/yr
Recent acceleration
Acceleration
+60.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
11.5x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $357.01M | +196.9% |
| 2024 | $120.26M | +9.4% |
| 2023 | $109.97M | +60.8% |
| 2022 | $68.39M | +42.6% |
| 2021 | $47.98M | +54.7% |
| 2020 | $31.00M | -59.2% |
| 2019 | $76.02M | +84.2% |
| 2018 | $41.26M | - |